Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity

Clinical Immunology : the Official Journal of the Clinical Immunology Society
C J SerranoJosé Antonio Enciso-Moreno

Abstract

Regulatory T cells (Tregs), a subset of CD4+ T cells related with immune regulation, have been associated with active and latent tuberculosis infection (LTBI). Treg frequencies were evaluated by multicolor flow cytometry (FC) in peripheral blood mononuclear cells (PBMCs) stimulated with mycobacterial antigens ESAT-6, CFP-10, and TB7.7 to assess their capacity to distinguish subjects with different reactivity to the QuantiFERON-TB® Gold In-Tube (QFT-IT) test and the tuberculin skin test (TST). Increased frequencies of CD4+CD25highCD39+ cells were found for the [TST+, QTF+] compared with the [TST+, QTF-] group. Also, higher frequencies were observed for the [TST+, QTF+] compared with the [TST+, QTF-] and [TST-, QTF-] groups in CD4+CD25highFoxp3+ and CD4+CD25highCD39+Foxp3+ populations. Receiver operating characteristics (ROC curve) analysis confirmed these discriminating results. QFT-IT and TST quantitative values correlated with several Treg population frequencies.

References

May 2, 2002·Clinical and Experimental Immunology·D S S RodriguesE G Kallas
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Mar 24, 2005·Human Immunology·Leonie S TaamsFloris P J G Lafeber
Dec 13, 2005·American Journal of Respiratory and Critical Care Medicine·Valerie Guyot-RevolAjit Lalvani
Dec 13, 2006·Nature Reviews. Microbiology·David G Russell
Jan 20, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Xinchun ChenEmmanuel Katsanis
Mar 24, 2009·Annual Review of Immunology·Yasmine Belkaid, Kristin Tarbell
Apr 18, 2009·Nature Protocols·James J MoonMarc K Jenkins
Apr 21, 2009·Trends in Microbiology·Douglas B YoungRobert J Wilkinson
May 26, 2009·Immunity·Maria A Curotto de Lafaille, Juan J Lafaille
Oct 27, 2009·Nature Reviews. Microbiology·Clifton E BarryDouglas Young
Nov 26, 2009·The Journal of Infectious Diseases·Subash BabuThomas B Nutman
Jul 14, 2010·The Journal of Infectious Diseases·Angela M GreenJoanne L Flynn
Jul 12, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P WeinfurterUNKNOWN Tuberculosis Epidemiological Studies Consortium
Feb 14, 2013·Journal of the Royal Army Medical Corps·M J World
Mar 20, 2013·Archives of Medical Research·Carmen Judith Serrano-EscobedoJoel Monárrez-Espino
Apr 23, 2013·Trends in Molecular Medicine·Luca AntonioliGyörgy Haskó
Mar 19, 2014·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Matteo ZignolKatherine Floyd
Apr 15, 2014·Clinical Epidemiology·Alberto MatteelliAnna Cc Carvalho
May 21, 2014·Cellular Immunology·R E García JacoboM H García Hernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here